U.S. Pharma Stock News

Recent performance snapshot Zurn Elkay Water Solutions (ZWS) has drawn attention after a period of mixed share performance, with the stock showing negative moves over the past week, month, past 3 months, and year to date, alongside a positive 1 year total return. See our latest analysis for Zurn Elkay Water Solutions. At a share price of US$45.73, Zurn Elkay Water Solutions has seen short term momentum fade, with a 1 month share price return decline of 11.29%. However, its 1 year total...

If you are wondering whether Daqo New Energy is priced attractively today, the key question is how its current share price lines up with its underlying business value. The stock last closed at US$23.11, with returns of 4.3% over 7 days, a 10.5% decline over 30 days, a 22.1% decline year to date, and a 21.2% gain over 1 year that sits against much weaker 3 year and 5 year returns of 49.4% and 70.8% declines. Recent price moves have been shaped by ongoing sector wide discussion around solar...

Recent performance snapshot Mueller Water Products (MWA) has drawn fresh attention after a mixed stretch in its share price, with a recent 0.4% daily gain contrasting with a 0.7% decline over the past week and a 5.8% pullback over the past month. Even so, the stock shows an 11.0% return over the past 3 months and a 15.9% gain year to date, alongside a 2.9% total return over the past year. This has prompted a closer look at how these moves line up with the company’s fundamentals. See our...

If you are wondering whether BrightView Holdings is attractively priced or just a value trap, you are in the right place to unpack what the current share price really reflects. The stock last closed at US$11.81, with returns of 7.2% decline over 7 days, 15.5% decline over 30 days, a 6.3% decline year to date, a 10.9% decline over 1 year, a 102.6% gain over 3 years and a 30.4% decline over 5 years. Taken together, this gives you a mixed picture of how sentiment has shifted over different...

If you are wondering whether Trinity Capital's current share price reflects its true worth, you are not alone. This article is set up to help you look past the headline numbers and into what the valuation actually implies. The stock last closed at US$14.42, with returns of 7.9% over 1 year and much stronger gains over 3 and 5 years. However, the last 7 and 30 days show declines of 3.3% and 8.8% that may have shifted how investors see the balance between opportunity and risk. Recent coverage...

Haemonetics (NYSE:HAE) is expanding its product portfolio in the Hospital division with new technology and acquisitions. The company has fully transitioned from legacy PCS2 plasma collection devices to its NexSys PCS system with Persona Technology. Recent purchases of Attune Medica and OpSens add new capabilities in hospital and interventional cardiology settings. For you as an investor, this shift is about more than one product line. Haemonetics operates across blood management and...

If you are wondering whether Karman Holdings at around US$99.98 is still fairly priced or starting to look stretched, you are not alone. The stock has seen a 25.7% return over the past 30 days, 30.1% year to date, and 201.5% over the last year, with a small 0.6% decline in the most recent 7 days. Recent coverage has focused on Karman Holdings as an evergreen story for investors who want ongoing insight into the stock, with attention on how its share price has moved over different time frames...

Why Sonida Senior Living Is On Investors’ Radar Sonida Senior Living (SNDA) has drawn attention after recent share price swings, with a 1 day return of 4.34% contrasting with a 4.28% decline over the past week. This has prompted closer portfolio reviews. See our latest analysis for Sonida Senior Living. That sharp 1 day share price return of 4.34% comes after a softer 7 day share price return of 4.28%. Sonida Senior Living still has a 90 day share price return of 13.06% and a 1 year total...

If you are wondering whether ACADIA Pharmaceuticals at around US$20.61 is offering good value or just fresh risk, you are in the right place for a closer look at what that price might represent. The share price has seen a 7% decline over the last week, an 8.3% decline over the last month, but a 17.8% return over the last year. This can leave investors questioning whether recent weakness is a setback or a reset after earlier gains. Recent attention on ACADIA has centered on its product...

In early March 2026, Abercrombie & Fitch Co. reported past fourth-quarter and full-year 2025 results with record sales of US$1,669.8 million and US$5,266.29 million respectively, even as net income eased to US$172.13 million for the quarter and US$506.92 million for the year, alongside ongoing share repurchases and new store expansion plans. The company coupled this performance with 2026 guidance targeting low single-digit net sales growth, double-digit operating margins of about 12.0% to...

Norwegian Cruise Line Holdings (NYSE:NCLH) has introduced its next-generation ship, Norwegian Luna, expanding its fleet with new onboard experiences and itineraries. The ship features updated entertainment, dining concepts, and family-focused amenities, along with itineraries that highlight destinations such as Great Stirrup Cay. This launch reflects a significant product refresh aimed at broadening the guest base, including multi generational families. Norwegian Cruise Line Holdings,...

If you are wondering whether Pulse Biosciences at around US$21.57 offers good value or is running ahead of itself, you are not alone. The stock has seen mixed recent moves, with an 18.9% return over the last 7 days, a 14.6% decline over the past 30 days, a 61.1% return year to date and a 27.6% return over the past year, while the 3 year return is very large and the 5 year return sits at an 8.5% decline. These moves have come against a backdrop of ongoing attention on Pulse Biosciences and...

Eastman Chemical (NYSE:EMN) has rolled out a new 2026 self help plan focused on deeper cost reductions and operational efficiency. The plan also targets expanded capital returns, signaling an intention to keep shareholder payouts in focus alongside internal improvements. Management is positioning the initiative as a material shift in how the company runs its business and allocates cash over the next few years. Eastman Chemical is launching this plan at a time when the stock has faced mixed...

Matador Resources (MTDR) is back on investors’ radar after BMO Capital reaffirmed its positive view on the stock, citing core acreage quality, operational execution, production trends, and recent balance sheet moves. See our latest analysis for Matador Resources. The 1-month share price return of 17.77% and 90-day share price return of 29.11% suggest momentum has been building. The 5-year total shareholder return of 152.21% points to meaningful longer term value creation for investors who...

If you are wondering whether Himax Technologies at around US$9.84 still offers value or if the easy gains are gone, this article unpacks what the current price might be implying. The stock has posted returns of 33.0% over the last 7 days, 19.3% over 30 days, 15.4% year to date and 14.9% over 1 year, with a 3 year return of 46.0% and 5 year return of 1.7% that give important context for any valuation discussion. Recent coverage has focused on Himax's role as a semiconductor player in display...

Why TransUnion Is Back on Investors’ Radar TransUnion (TRU) has drawn fresh attention after a recent swing in its share performance, with the stock showing a 0.5% gain over the past day but a 9.6% decline over the past week. This short term volatility comes against a backdrop of mixed returns, including a 2.5% decline over the past month and a 17.4% decline over the past 3 months. This may prompt investors to reassess the company’s fundamentals. See our latest analysis for TransUnion. At...

If you are wondering whether Hartford Insurance Group's current share price still reflects good value, this article walks through what the numbers actually say rather than relying on headlines or hype. The stock last closed at US$132.93, with a 4.5% decline over the past week and a 6.4% decline over the past month, while the 1 year return stands at 13.7% and the 3 and 5 year returns are 114.1% and 117.3% respectively. Recent coverage around Hartford Insurance Group has focused on the company...

Via Transportation (NYSE:VIA) reports material improvements in city transit performance in the City of Mobile, including better reliability and staffing outcomes without additional budget. The company expands its work with Transport for West Midlands in the UK, adding Citymapper integration to support future regional transit planning. These developments highlight Via’s growing role as a partner for large scale public transit transformation across multiple geographies. Via Transportation,...

California has introduced new driving laws affecting ignition interlock devices, penalties for intoxication related vehicular manslaughter, and rules for autonomous vehicles and electric motorcycles. Mercury General (NYSE:MCY), through its Mercury Insurance brand, has highlighted these legal updates for policyholders and investors. The company views the changes as relevant for risk assessment, claims patterns, and driver behavior in its core California market. For Mercury General, which...

MicroVision, Inc. has reported its full-year 2025 results, with sales of US$1.21 million compared to US$4.70 million in 2024 and a net loss of US$94.98 million versus US$96.92 million, while basic loss per share from continuing operations narrowed to US$0.35 from US$0.46. The combination of falling revenue and a slightly smaller loss highlights the company’s challenge of scaling its business while still tightly managing costs. With sales declining year over year but net loss narrowing, we’ll...

If you are wondering whether Ormat Technologies' current share price lines up with its underlying value, this article will walk you through the numbers in a straightforward way. The stock closed at US$110.38, with returns of 1.4% over 7 days, a 10.4% decline over 30 days, a 2.9% decline year to date, and a 54.4% return over 1 year, alongside 3 year and 5 year returns of 39.8% and 49.7% respectively. Recent coverage has focused on Ormat Technologies as a long standing player in the US...

If you are wondering whether Delta Air Lines is priced attractively right now, this article walks through what the current share price might imply about its underlying value. The stock last closed at US$58.78, with a 7 day return of 0.4% decline, a 30 day return of 17.7% decline, a year to date return of 14.9% decline, a 1 year return of 27.3%, and a 3 year return of 83.8%. Recent coverage around Delta has focused on how investors are reassessing major US airlines as a group, including...

Ardelyx recently reported the peer-reviewed publication of pooled clinical data showing its IBSRELA (tenapanor) therapy delivered earlier and sustained symptom relief in adults with IBS-C, with no new safety concerns identified. The analysis offers clinicians practical guidance on treatment duration and symptom timelines, potentially influencing how IBSRELA is positioned and used in everyday care. We’ll now examine how this new evidence of earlier and sustained IBS-C symptom relief could...

Zacks Equity Research recently highlighted Spire Inc.’s long-term infrastructure and innovation plans, including an expected US$11.20 billion in capital investments over the next decade, alongside its current 3.59% dividend yield and analyst estimates for long-term earnings growth. The analysis underscores how these planned investments and anticipated earnings expansion could influence Spire’s role in a gas utility sector balancing aging infrastructure, renewable competition, and the...